Singapore Researchers Discover New Biomarker for Cancer Prognosis
Duke-NUS scientists identify MBNL1 as a cancer biomarker associated with poorer disease outcomes, opening new doors for cancer therapeutics. Cancer incidence worldwide continues to increase, with the...